resveratrol has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beach, LB; Dapp, MJ; Heineman, RH; Mansky, LM; Martin, JL; Patterson, SE; Rawson, JM; Schnettler, EK | 1 |
| Kolodziejczyk, J; Nowak, P; Olas, B; Ponczek, M; Wachowicz, B | 1 |
| Bechmann, I; Blumenauer, V; Jogschies, P; Nowicki, M; Schube, U; Serke, H | 1 |
3 other study(ies) available for resveratrol and deferoxamine
| Article | Year |
|---|---|
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Deoxycytidine; Enzyme Inhibitors; Genes, Reporter; Green Fluorescent Proteins; HIV-1; Humans; Luminescent Proteins; Mutation; Red Fluorescent Protein; Resveratrol; Ribonucleotide Reductases; Stilbenes; Viral Proteins | 2013 |
Protective effects of resveratrol against oxidative/nitrative modifications of plasma proteins and lipids exposed to peroxynitrite.
Topics: Blood Proteins; Deferoxamine; Humans; Lipid Peroxidation; Lipids; Oxidation-Reduction; Peroxynitrous Acid; Resveratrol; Stilbenes; Tyrosine | 2006 |
Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration.
Topics: Antioxidants; Cell Death; Cells, Cultured; Cytoprotection; Deferoxamine; Female; Granulosa Cells; Humans; Lipoproteins, LDL; Oxidative Stress; Resveratrol; Stilbenes | 2014 |